Potent chemical chaperone compounds for GM1-gangliosidosis: N-substituted (+)-conduramine F-4 derivatives
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potent chemical chaperone compounds for GM1-gangliosidosis: N-substituted (+)-conduramine F-4 derivatives
Authors
Keywords
-
Journal
MedChemComm
Volume 6, Issue 2, Pages 306-310
Publisher
Royal Society of Chemistry (RSC)
Online
2014-11-04
DOI
10.1039/c4md00270a
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural Basis of Pharmacological Chaperoning for Human β-Galactosidase
- (2014) Hironori Suzuki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacological Chaperones as Therapeutics for Lysosomal Storage Diseases
- (2013) Robert E. Boyd et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Bicyclic 1-Deoxygalactonojirimycin Derivative as a Novel Pharmacological Chaperone for GM1 Gangliosidosis
- (2013) Tomoko Takai et al. MOLECULAR THERAPY
- Concise syntheses of potent chaperone drug candidates, N-octyl-4-epi-β-valinenamine (NOEV) and its 6-deoxy derivative, from (+)-proto-quercitol
- (2012) Shinichi Kuno et al. CARBOHYDRATE RESEARCH
- Tuning glycosidase inhibition through aglycone interactions: pharmacological chaperones for Fabry disease and GM1 gangliosidosis
- (2012) M. Aguilar-Moncayo et al. CHEMICAL COMMUNICATIONS
- Discovery, Structure–Activity Relationship, and Biological Evaluation of Noninhibitory Small Molecule Chaperones of Glucocerebrosidase
- (2012) Samarjit Patnaik et al. JOURNAL OF MEDICINAL CHEMISTRY
- Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy
- (2012) Brigitte A. Rigat et al. MOLECULAR GENETICS AND METABOLISM
- Pharmacological Enhancement of α-Glucosidase by the Allosteric Chaperone N-acetylcysteine
- (2012) Caterina Porto et al. MOLECULAR THERAPY
- Determining the Role of the Aromatic Ring ofN-Arylmethylent-conduramine F-1 in their Interactions with α-Glucosidases by Saturation Transfer Difference NMR Spectroscopy Experiments
- (2012) Antonio Hernández Daranas et al. ChemistryOpen
- Identification and Characterization of Pharmacological Chaperones to Correct Enzyme Deficiencies in Lysosomal Storage Disorders
- (2011) Kenneth J. Valenzano et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- 1-Deoxy-d-galactonojirimycins with dansyl capped N-substituents as β-galactosidase inhibitors and potential probes for GM1 gangliosidosis affected cell lines
- (2011) Richard F.G. Fröhlich et al. CARBOHYDRATE RESEARCH
- Chemical chaperone therapy: chaperone effect on mutant enzyme and cellular pathophysiology in β-galactosidase deficiency
- (2011) Katsumi Higaki et al. HUMAN MUTATION
- DLHex-DGJ, a novel derivative of 1-deoxygalactonojirimycin with pharmacological chaperone activity in human GM1-gangliosidosis fibroblasts
- (2010) Katrin Fantur et al. MOLECULAR GENETICS AND METABOLISM
- (+)-proto-Quercitol, a natural versatile chiral building block for the synthesis of the α-glucosidase inhibitors, 5-amino-1,2,3,4-cyclohexanetetrols
- (2009) Sumrit Wacharasindhu et al. TETRAHEDRON LETTERS
- A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity
- (2007) Jian-Qiang Fan BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search